# Phase 1 Trial of JTM201 in Subjects With Post-stroke Upper Limb Spasticity

> **NCT07292025** · PHASE1 · COMPLETED · sponsor: **Jetema Co., Ltd.** · enrollment: 30 (actual)

## Conditions studied

- Upper Limb Spasticity Post-Stroke

## Interventions

- **DRUG:** JTM201 in normal saline
- **DRUG:** BOTOX 100U in normal saline

## Key facts

- **NCT ID:** NCT07292025
- **Lead sponsor:** Jetema Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-29
- **Primary completion:** 2024-04-22
- **Final completion:** 2024-09-04
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07292025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07292025, "Phase 1 Trial of JTM201 in Subjects With Post-stroke Upper Limb Spasticity". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07292025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*